These effects were present in the KRAS codon @/@ wild-type population ( HR OS : @ ; HR PFS : @ ) , while no impact of primary tumor location was evident in patients with KRAS codon @/@ mutant tumors ( HR OS : @ ; HR PFS : @ ) .